Shares of Tata Elxsi, a design and technology services company under the Tata Group, fell about 5% to an intraday low of ₹4,418 on the National Stock Exchange following the announcement of its Q4FY26 results. Despite a 27.8% increase in profit after tax to ₹220.4 crore and a 9.4% rise in revenue from operations to ₹993.8 crore, analysts expressed caution due to missed revenue growth estimates, particularly in the Healthcare vertical, which saw a 13.7% decline quarter-on-quarter. The company's Ebitda margin improved to 24.6%, and a final dividend of ₹75 crore per share has been proposed. Brokerages like PL Capital and SBI Securities have downgraded the stock to 'Hold', citing challenges in the Healthcare and Life Sciences sectors and a cautious outlook for FY27, although they believe that current valuations may present a long-term investment opportunity.